July 15, 2020

The Niche

Knoepfler lab stem cell blog

Month: July 2011

2 min read

Stem Cell Tourism is a blanket term now used to refer to patients receiving non-FDA approved stem cell treatments either by traveling here within the U.S. or more often outside the U.S. Clinics are sprouting up all over the world offering treatments based on stem cells. The science behind these is often non-existent. Most stem cell scientists are very worried about this situation. But as both a stem cell scientist and also a cancer survivor, I am very sensitive to the situation of patients …Read More

2 min read

Advanced Cell Technology  (ACT) announced today that it has treated two patients in its clinical trials: one for Stargardt’s Macular Dystrophy (see official trial page for a lot more info) and one for Dry Age-Related Macular Degeneration (see official trial page here for a lot more info). The patients underwent the treatment at UCLA and each reportedly received about 50,000 cells as a transplant into the eye. The cells being used are retinal pigmented epithelial cells produced from human embryonic stem cells (hESC). The primary …Read More

3 min read

There has been a largely media-fed hullabaloo about the salary for the new Chair of CIRM, the California Institute for Regenerative Medicine, $400,000. Now don’t get me wrong, that sounds like a lot of money to me personally, but we need to put it in perspective and when we do, the salary is reasonable and appropriate. The Sac Bee and LA Times have pounded CIRM about the salary issue and used the issue as a can opener to open a manufactured can of worms, …Read More